Varex Imaging (VREX) Cash from Financing Activities (2016 - 2026)
Varex Imaging (VREX) posted quarterly Cash from Financing Activities of -$29.3 million for Q2 2026, down 4085.71% year-over-year from $735125.4 in Q2 2025, and down 1731.25% quarter-over-quarter from -$1.6 million in Q1 2026.
Varex Imaging (VREX) Cash from Financing Activities (2016 - 2026) Analysis & Trends
Varex Imaging (VREX) has reported Cash from Financing Activities for 11 consecutive years, with -$29.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 4085.71% year-over-year to -$29.3 million; the TTM figure through Apr 2026 stood at -$231.0 million (down 286.44% YoY), while the FY2025 annual figure was -$75.9 million, down 2200.0% from the prior year.
- Cash from Financing Activities retreated to -$29.3 million in Q2 2026 per VREX's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $124.9 million in Q1 2025 and bottomed at -$201.2 million in Q3 2025.
- Historically, Cash from Financing Activities has averaged -$8.2 million across 5 years, with a median of -$700000.0 in 2023.
- On a YoY basis, Cash from Financing Activities climbed as much as 7447.06% in 2025 and fell as far as 18190.91% in 2025.
- Varex Imaging's Cash from Financing Activities stood at -$400000.0 in 2022, then plunged by 325.0% to -$1.7 million in 2023, then jumped by 147.06% to $800000.0 in 2024, then jumped by 37.5% to $1.1 million in 2025, then slumped by 2763.64% to -$29.3 million in 2026.
- Business Quant data shows VREX's Cash from Financing Activities at -$29.3 million in Q2 2026, -$1.6 million in Q1 2026, and $1.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Varex Imaging | 778.22 Mn | 679.02 Mn | 76.70 Mn | -1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -1.20 Mn |
| Jul 3, 2026 | -1.20 Mn |
| Apr 3, 2026 | -29.30 Mn |
| Apr 3, 2026 | -29.30 Mn |
| Jan 2, 2026 | -1.60 Mn |
| Jan 2, 2026 | -1.60 Mn |
| Oct 3, 2025 | 1.10 Mn |
| Oct 3, 2025 | 1.10 Mn |
| Jul 4, 2025 | -201.20 Mn |
| Jul 4, 2025 | -201.20 Mn |
| Apr 4, 2025 | -700,000.00 |
| Apr 4, 2025 | -700,000.00 |
| Jan 3, 2025 | 124.90 Mn |
| Jan 3, 2025 | 124.90 Mn |
| Sep 27, 2024 | 800,000.00 |
| Sep 27, 2024 | 800,000.00 |
| Jun 28, 2024 | -1.10 Mn |
| Jun 28, 2024 | -1.10 Mn |
| Mar 29, 2024 | -1.30 Mn |
| Mar 29, 2024 | -1.30 Mn |